Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
Urpu Salmenniemi, Kari Remes
Hematology Reports · 2012
doi:10.4081/hr.2012.e13 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.